Viral infections associated with Kawasaki disease

Luan-Yin Chang, Chun-Yi Lu, Pei-Lan Shao, Ping-Ing Lee, Ming-Tai Lin, Tsui-Yien Fan, Ai-Ling Cheng, Wan-Ling Lee, Jen-Jan Hu, Shu-Jen Yeh, Chien-Chih Chang, Bor-Luen Chiang, Mei-Hwan Wu, Li-Min Huang, Luan-Yin Chang, Chun-Yi Lu, Pei-Lan Shao, Ping-Ing Lee, Ming-Tai Lin, Tsui-Yien Fan, Ai-Ling Cheng, Wan-Ling Lee, Jen-Jan Hu, Shu-Jen Yeh, Chien-Chih Chang, Bor-Luen Chiang, Mei-Hwan Wu, Li-Min Huang

Abstract

Background/purpose: Kawasaki disease (KD) is a disease of unknown cause. To investigate the infectious etiology of Kawasaki disease, we initiated a prospective case-control study to investigate possible links between common viral infections and Kawasaki disease.

Methods: We enrolled 226 children with KD and 226 age- and sex-matched healthy children from February 2004 to March 2010. Throat and nasopharyngeal swabs were taken for both viral isolation and polymerase chain reaction (PCR) for various viruses.

Results: The mean age of the 226 KD cases was 2.07 years, and the male to female ratio was 1.43 (133 boys to 93 girls). Their mean fever duration was 7.5 days with a mean peak temperature of 39.7°C. In addition to the typical symptoms of fever, neck lymphadenopathy, lip fissure and/or strawberry tongue, skin rash, nonpurulent bulbar conjunctivitis, palm/sole erythema, and induration followed by periungual desquamation, these KD cases also exhibited cough (69%), rhinorrhea (58%), and diarrhea (45%). Cases of KD had a significantly higher positive rate of viral isolation in comparison with the control group (7.5% vs. 2.2%, p = 0.02). Compared with the control group, cases of KD were more likely to have overall positive rates of viral PCR (50.4% vs. 16.4%, p < 0.001) and for various viruses including enterovirus (16.8% vs. 4.4%, p < 0.001), adenovirus (8.0% vs. 1.8%, p = 0.007), human rhinovirus (26.5% vs. 9.7%, p < 0.001), and coronavirus (7.1% vs. 0.9%, p = 0.003).

Conclusion: We found that some common respiratory viruses, such as adenoviruses, enteroviruses, rhinoviruses, and coronaviruses, were associated with KD cases.

Keywords: Kawasaki disease; virus.

Copyright © 2014. Published by Elsevier B.V.

Figures

Figure 1
Figure 1
Age-specific case number and cumulative percentage of cases with Kawasaki disease.

References

    1. Kawasaki T. Pediatric acute febrile mucocutaneous lymph node syndrome with characteristic desquamation of fingers and toes: my clinical observation of fifty cases. Japanese J of Allergy. 1967;178:178–222.
    1. Yanagawa H., Yashiro M., Nakamura Y., Kawasaki T., Kato H. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics. 1995;95:475–479.
    1. Du Z.D., Zhao D., Du J., Zhang Y.L., Lin Y., Liu C. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004. Pediatr Infect Dis J. 2007;26:449–451.
    1. Holman R.C., Curns A.T., Belay E.D., Steiner C.A., Schonberger L.B. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112:495–501.
    1. Belay E.D., Holman R.C., Maddox R.A., Foster D.A., Schonberger L.B. Kawasaki syndrome hospitalizations and associated costs in the United States. Public Health Rep. 2003;118:464–469.
    1. Gardner-Medwin J.M., Dolezalova P., Cummins C., Southwood T.R. Incidence of Henoch–Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197–1202.
    1. Park Y.W., Park I.S., Kim C.H., Ma J.S., Lee S.B., Kim C.H. Epidemiologic study of Kawasaki disease in Korea, 1997–1999: comparison with previous studies during 1991–1996. J Korean Med Sci. 2002;17:453–456.
    1. Royle J.A., Williams K., Elliott E., Sholler G., Nolan T., Allen R. Kawasaki disease in Australia, 1993–95. Arch Dis Child. 1998;78:33–39.
    1. Schiller B., Fasth A., Bjorkhem G., Elinder G. Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr. 1995;84:769–774.
    1. Salo E. Kawasaki disease in Finland in 1982–1992. Scand J Infect Dis. 1993;25:497–502.
    1. Chang L.Y., Chang I.S., Lu C.Y., Chiang B.L., Lee C.Y., Chen P.J. Epidemiological features of Kawasaki disease in Taiwan from 1996 to 2002. Pediatrics. 2004;114:e678–e682.
    1. Yanagawa H., Nakamura Y., Ojima T., Yashiro M., Tanihara S., Oki I. Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect Dis J. 1999;18:64–66.
    1. Nakamura Y., Yashiro M., Yanagawa H. Validity of the infectious disease surveillance system on comparison of nationwide surveys of Kawasaki disease during a 10-year period. Nippon Koshu Eisei Zasshi. 2000;47:1029–1035.
    1. Nakamura Y., Yanagawa I., Kawasaki T. Temporal and geographic clustering of Kawasaki disease in Japan. Prog Clin Biol Res. 1987;250:19–32.
    1. Uchiyama T., Kato H. The pathogenesis of Kawasaki disease and superantigens. Jpn J Infect Dis. 1999;52:141–145.
    1. Schrag S.J., Besser R.E., Olson C., Burns J.C., Arguin P.M., Gimenez-Sanchez F. Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County. Pediatr Infect Dis J. 2000;19:17–22.
    1. Chua P.K., Nerurkar V.R., Yu Q., Woodward C.L., Melish M.E., Yanagihara R. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae. Pediatr Infect Dis J. 2000;19:477–479.
    1. Bell D.M., Brink E.W., Nitzkin J.L., Hall C.B., Wulff H., Berkowitz I.D. Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med. 1981;304:1568–1575.
    1. Dean A.G., Melish M.E., Hicks R., Palumbo N.E. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr. 1982;100:552–557.
    1. Keren G., Barzilay Z., Alpert G., Spirer Z., Danon Y. Mucocutaneous lymph node syndrome (Kawasaki disease) in Israel. A review of 13 cases: is pseudomonas infection responsible? Acta Paediatr Scand. 1983;72:455–458.
    1. Hansen R.C. Staphylococcal scalded skin syndrome, toxic shock syndrome, and Kawasaki disease. Pediatr Clin North Am. 1983;30:533–544.
    1. Reller M., DeCristofaro J., Schwartz D.C. Coronary aneurysms in a patient with atypical Kawasaki syndrome and a streptococcal infection. Pediatr Cardiol. 1984;5:205–207.
    1. Umehara K., Kuno-Sakai H., Iwasaki H., Takesue R., Hoshi N., Furukawa T. Trial of isolation of a virus from sera of patients with Kawasaki disease. Tokai J Exp Clin Med. 1986;11:19–21.
    1. Klein B.S., Rogers M.F., Patrican L.A., White M.C., Burgdorfer W., Schell W.L. Kawasaki syndrome: a controlled study of an outbreak in Wisconsin. Am J Epidemiol. 1986;124:306–316.
    1. Kikuta H., Taguchi Y., Tomizawa K., Kojima K., Kawamura N., Ishizaka A. Epstein–Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature. 1988;333:455–457.
    1. Rauch A.M. Kawasaki syndrome: issues in etiology and treatment. Adv Pediatr Infect Dis. 1989;4:163–182.
    1. Okano M., Luka J., Thiele G.M., Sakiyama Y., Sakiyama Y., Matsumoto S. Human herpesvirus 6 infection and Kawasaki disease. J Clin Microbiol. 1989;27:2379–2380.
    1. Enders G., Biber M., Meyer G., Helftenbein E. Prevalence of antibodies to human herpesvirus 6 in different age groups, in children with exanthema subitum, other acute exanthematous childhood diseases, Kawasaki syndrome, and acute infections with other herpesviruses and HIV. Infection. 1990;18:12–15.
    1. Marchette N.J., Melish M.E., Hicks R., Kihara S., Sam E., Ching D. Epstein–Barr virus and other herpesvirus infections in Kawasaki syndrome. J Infect Dis. 1990;161:680–684.
    1. Okano M., Thiele G.M., Sakiyama Y., Matsumoto S., Purtilo D.T. Adenovirus infection in patients with Kawasaki disease. J Med Virol. 1990;32:53–57.
    1. Akiyama T., Osawa N., Shimanuki K., Yashiro K., Oyake T. Possible role of Streptococcus pyogenes in mucocutaneous lymph node syndrome. XII. Variable responses of platelets in MCLS seem to be explainable by streptococcal pyrogenic exotoxin. Acta Paediatr Jpn. 1990;33:20–26.
    1. Kikuta H., Matsumoto S., Osato T. Kawasaki disease and Epstein-Barr virus. Acta Paediatr Jpn. 1991;33:765–770.
    1. Lin C.Y., Chen I.C., Cheng T.I., Liu W.T., Hwang B., Chiang B.N. Virus-like particles with reverse transcriptase activity associated with Kawasaki disease. Med Virol. 1992;38:175–182.
    1. Abinun M., Cant A.J. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1994;343:300.
    1. Anderson D.G., Warner G., Barlow E. Kawasaki disease associated with streptococcal infection within a family. J Paediatr Child Health. 1995;31:355–357.
    1. Morita A., Imada Y., Igarashi H., Yutsudo T. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease. Microbiol Immunol. 1997;41:895–900.
    1. Barton M., Melbourne R., Morais P., Christie C. Kawasaki syndrome associated with group A streptococcal and Epstein–Barr virus co-infections. Ann Trop Paediatr. 2002;22:257–260.
    1. Kafetzis D.A., Maltezou H.C., Constantopoulou I., Antonaki G., Liapi G., Mathioudakis I. Lack of association between Kawasaki syndrome and infection with Rickettsia conorii, Rickettsia typhi, Coxiella burnetii or Ehrlichia phagocytophila group. Pediatr Infect Dis J. 2001;20:703–706.
    1. Rowley A.H., Baker S.C., Shulman S.T., Fox L.M., Takahashi K., Garcia F.L. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis. 2005;192:1757–1766.
    1. Lynch M., Holman R.C., Mulligan A., Belay E.D., Schonberger L.B. Kawasaki syndrome hospitalizations in Ireland, 1996 through 2000. Pediatr Infect Dis J. 2003;22:959–963.
    1. Park Y.W., Han J.W., Park I.S., Kim C.H., Cha S.H., Ma J.S. Kawasaki disease in Korea, 2003–2005. Pediatr Infect Dis J. 2007;26:821–823.
    1. Ng Y.M., Sung R.Y., So L.Y., Fong N.C., Ho M.H., Cheng Y.W. Kawasaki disease in Hong Kong, 1994 to 2000. Hong Kong Med J. 2005;11:331–335.
    1. Burns J.C., Cayan D.R., Tong G., Bainto E.V., Turner C.L., Shike H. Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology. 2005;16:220–225.
    1. Jordan-Villegas A., Chang M.L., Ramilo O., Mejías A. Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr Infect Dis J. 2010;29:770–772.
    1. Moreira A., Leite I., Baptista A., Osório Ferreira E. Kawasaki disease associated with parainfluenza type 3 virus infection. Acta Dermatovenerol Croat. 2010;18:120–123.
    1. Jaggi P., Kajon A.E., Mejias A., Ramilo O., Leber A. Human adenovirus infection in Kawasaki disease: a confounding bystander? Clin Infect Dis. 2013;56:58–64.
    1. Kim J.H., Yu J.J., Lee J., Kim M.N., Ko H.K., Choi H.S. Detection rate and clinical impact of respiratory viruses in children with Kawasaki disease. Korean J Pediatr. 2012;55:470–473. 48.
    1. Lu C.Y., Chang L.Y., Chen P.J., Xia N.S., Shao P.L., Huang L.M. A highly specific ELISA for diagnosis of 2009 influenza A (H1N1) virus infections. J Formosan Med Assoc. 2012;111:693–697.
    1. Tseng Y.T., Sun H.Y., Chang S.Y., Wu C.H., Liu W.C., Wu P.Y. Seroprevalence of hepatitis virus infection in men who have sex with men aged 18–40 years in Taiwan. J Formosan Med Assoc. 2012;111:431–438.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera